Back to Search

MARISOL NARDI, M.D.

M.D.

Hospitalist Physician

NPI: 1154671717IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

276518(NY)
Hospitalist PhysicianPrimary

Hospitalist

Code: 208M00000X

276518(NY)

CMS Specialties

PrimaryINTERNAL MEDICINE

Education

OTHER

Class of 2007

Research & Publications (20)

Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin.
PMID 18056258·J Biol Chem·2008
8-other
Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12-lipoxygenase, and NADPH oxidase.
PMID 17545506·Blood·2007
7-preclinical
Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway.
PMID 15057303·J Clin Invest·2004
8-other
Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia.
PMID 11551503·Cell·2001
7-preclinical
Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrombocytopenia in HIV-1-ITP patients.
PMID 10859334·J Exp Med·2000
7-preclinical
Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia.
PMID 19023115·Blood·2009
7-preclinical
Aceclidine, brimonidine tartrate, and dapiprazole: comparison of miotic effect and tolerability under different lighting conditions.
PMID 19101423·J Cataract Refract Surg·2009
4-observational
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response.
PMID 19036077·Br J Haematol·2009
3-trial
Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures.
PMID 19028743·Br J Ophthalmol·2009
4-observational
Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer.
PMID 19329221·Lung Cancer·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
170 WILLIAM ST
NEW YORK, NY 10038

Quick Facts

NPI
1154671717
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
19
Publications
20

Are you this provider?

Claim Your Profile